Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson’s Disease by Suppressing the JNK/AP-1 Pathway

Compound Dihuang Granule (CDG) is widely used in traditional Chinese medicine (TCM) for the treatment of Parkinson’s disease (PD). It has been shown to alleviate PD symptoms. However, the molecular mechanisms of its action have not been established. To establish the molecular mechanisms of CDG again...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Yang, Yu-fang, Chen, Long, He, Zhu-qing, Bi, Dian-yong, Zhang, Lei, Xu, Yan-wu, He, Jian-cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060647/
https://www.ncbi.nlm.nih.gov/pubmed/33897417
http://dx.doi.org/10.3389/fphar.2021.621359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060647/
https://www.ncbi.nlm.nih.gov/pubmed/33897417
http://dx.doi.org/10.3389/fphar.2021.621359

Ejemplares similares